BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33975627)

  • 1. Functional mapping of androgen receptor enhancer activity.
    Huang CF; Lingadahalli S; Morova T; Ozturan D; Hu E; Yu IPL; Linder S; Hoogstraat M; Stelloo S; Sar F; van der Poel H; Altintas UB; Saffarzadeh M; Le Bihan S; McConeghy B; Gokbayrak B; Feng FY; Gleave ME; Bergman AM; Collins C; Hach F; Zwart W; Emberly E; Lack NA
    Genome Biol; 2021 May; 22(1):149. PubMed ID: 33975627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico identification and functional validation of allele-dependent AR enhancers.
    Garritano S; Romanel A; Ciribilli Y; Bisio A; Gavoci A; Inga A; Demichelis F
    Oncotarget; 2015 Mar; 6(7):4816-28. PubMed ID: 25693204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
    Baumgart SJ; Nevedomskaya E; Lesche R; Newman R; Mumberg D; Haendler B
    Mol Oncol; 2020 Sep; 14(9):2022-2039. PubMed ID: 32333502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
    Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
    Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers.
    Stelloo S; Bergman AM; Zwart W
    Endocr Relat Cancer; 2019 May; 26(5):R267-R285. PubMed ID: 30865928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor-binding sites are highly mutated in prostate cancer.
    Morova T; McNeill DR; Lallous N; Gönen M; Dalal K; Wilson DM; Gürsoy A; Keskin Ö; Lack NA
    Nat Commun; 2020 Feb; 11(1):832. PubMed ID: 32047165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells.
    Cinar B; Yeung F; Konaka H; Mayo MW; Freeman MR; Zhau HE; Chung LW
    Biochem J; 2004 Apr; 379(Pt 2):421-31. PubMed ID: 14715080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
    Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.
    Decker KF; Zheng D; He Y; Bowman T; Edwards JR; Jia L
    Nucleic Acids Res; 2012 Nov; 40(21):10765-79. PubMed ID: 23019221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation.
    Mahajan NP; Liu Y; Majumder S; Warren MR; Parker CE; Mohler JL; Earp HS; Whang YE
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8438-43. PubMed ID: 17494760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-tiered role of the pioneer factor GATA2 in promoting androgen-dependent gene expression in prostate cancer.
    Wu D; Sunkel B; Chen Z; Liu X; Ye Z; Li Q; Grenade C; Ke J; Zhang C; Chen H; Nephew KP; Huang TH; Liu Z; Jin VX; Wang Q
    Nucleic Acids Res; 2014 Apr; 42(6):3607-22. PubMed ID: 24423874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain protein 4 discriminates tissue-specific super-enhancers containing disease-specific susceptibility loci in prostate and breast cancer.
    Zuber V; Bettella F; Witoelar A; ; ; ; ; Andreassen OA; Mills IG; Urbanucci A
    BMC Genomics; 2017 Mar; 18(1):270. PubMed ID: 28359301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive functional annotation of 77 prostate cancer risk loci.
    Hazelett DJ; Rhie SK; Gaddis M; Yan C; Lakeland DL; Coetzee SG; ; ; Henderson BE; Noushmehr H; Cozen W; Kote-Jarai Z; Eeles RA; Easton DF; Haiman CA; Lu W; Farnham PJ; Coetzee GA
    PLoS Genet; 2014 Jan; 10(1):e1004102. PubMed ID: 24497837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers.
    Makkonen H; Kauhanen M; Paakinaho V; Jääskeläinen T; Palvimo JJ
    Nucleic Acids Res; 2009 Jul; 37(12):4135-48. PubMed ID: 19433513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes.
    Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K
    BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Receptor-Mediated Transcription in Prostate Cancer.
    Özturan D; Morova T; Lack NA
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen-mediated up-regulation of AR messenger RNA.
    Grad JM; Dai JL; Wu S; Burnstein KL
    Mol Endocrinol; 1999 Nov; 13(11):1896-911. PubMed ID: 10551783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor and MYC equilibration centralizes on developmental super-enhancer.
    Guo H; Wu Y; Nouri M; Spisak S; Russo JW; Sowalsky AG; Pomerantz MM; Wei Z; Korthauer K; Seo JH; Wang L; Arai S; Freedman ML; He HH; Chen S; Balk SP
    Nat Commun; 2021 Dec; 12(1):7308. PubMed ID: 34911936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.
    Wang D; Garcia-Bassets I; Benner C; Li W; Su X; Zhou Y; Qiu J; Liu W; Kaikkonen MU; Ohgi KA; Glass CK; Rosenfeld MG; Fu XD
    Nature; 2011 May; 474(7351):390-4. PubMed ID: 21572438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.